User menu

Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.

Bibliographic reference Swerts, Katrien ; De Moerloose, Barbara ; Dhooge, Catharina ; Brichard, Bénédicte ; Benoit, Yves ; et. al. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.. In: Cytometry. Part B, Clinical cytometry, Vol. 61, no. 1, p. 9-19 (2004)
Permanent URL http://hdl.handle.net/2078.1/27713
  1. Brodeur, Principles and practice of pediatric oncology, 761 (1997)
  2. Philip T, Ladenstein R, Lasset C, Hartmann O, Zucker J.M, Pinkerton R, Pearson A.D.J, Klingebiel T, Garaventa A, Kremens B, Bernard J.L, Rosti G, Chauvin F, 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions, 10.1016/s0959-8049(97)00324-9
  3. Cheung Irene Y., Chi Susan N., Cheung Nai-Kong V., Prognostic significance ofGAGE detection in bone marrows on survival of patients with metastatic neuroblastoma, 10.1002/1096-911x(20001201)35:6<632::aid-mpo31>3.0.co;2-1
  4. Seeger Robert C., Reynolds C. Patrick, Gallego Richard, Stram Daniel O., Gerbing Robert B., Matthay Katherine K., Quantitative Tumor Cell Content of Bone Marrow and Blood as a Predictor of Outcome in Stage IV Neuroblastoma: A Children’s Cancer Group Study, 10.1200/jco.2000.18.24.4067
  5. Fukuda Minoru, Miyajima Yuji, Miyashita Yoshiko, Horibe Keizo, Disease Outcome May Be Predicted by Molecular Detection of Minimal Residual Disease in Bone Marrow in Advanced Neuroblastoma: A Pilot Study : , 10.1097/00043426-200101000-00004
  6. Horibe Keizo, Fukuda Minoru, Miyajima Yuji, Matsumoto Kimikazu, Kondo Masaru, Inaba Jun, Miyashita Yoshiko, Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma, 10.1002/1096-911x(20010101)36:1<203::aid-mpo1049>3.0.co;2-t
  7. Matthay Katherine K., Villablanca Judith G., Seeger Robert C., Stram Daniel O., Harris Richard E., Ramsay Norma K., Swift Patrick, Shimada Hiroyuki, Black C. Thomas, Brodeur Garrett M., Gerbing Robert B., Reynolds C. Patrick, Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid, 10.1056/nejm199910143411601
  8. Moss, Blood, 76, 1879 (1990)
  9. Rill, Blood, 84, 380 (1994)
  10. Sze Tsang Kam, Kong Li Chi, Chiu Tsoi Wai, Leung Yonna, Ming Kong Shing Matthew, Wai Chik Ki, Lee Vincent, Heung Ling Ng Margaret, Man Pan Yuen Patrick, Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction, 10.1002/cncr.11389
  11. Cheung N K, Heller G, Kushner B H, Liu C, Cheung I Y, Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?, 10.1200/jco.1997.15.8.2807
  12. Komada, Cancer, 82, 591 (1998)
  13. Ambros P F, Méhes G, Hattinger C, Ambros I M, Luegmayr A, Ladenstein R, Gadner H, Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches – functional and prognastic information, 10.1038/sj.leu.2402023
  14. Nagai Jun-ichi, Ishida Yuji, Koga Noriko, Tanaka Yukichi, Ohnuma Kei, Toyoda Yasunori, Katoh Akinori, Hayabuchi Yohko, Kigasawa Hisato, A New Sensitive and Specific Combination of CD81/CD56/CD45 Monoclonal Antibodies for Detecting Circulating Neuroblastoma Cells in Peripheral Blood Using Flow Cytometry : , 10.1097/00043426-200001000-00004
  15. Burchill Susan A., Lewis Ian J., Abrams Keith R., Riley Richard, Imeson John, Pearson Andrew D.J., Pinkerton Ross, Selby Peter, Circulating Neuroblastoma Cells Detected by Reverse Transcriptase Polymerase Chain Reaction for Tyrosine Hydroxylase mRNA Are an Independent Poor Prognostic Indicator in Stage 4 Neuroblastoma in Children Over 1 Year, 10.1200/jco.2001.19.6.1795
  16. Cheung, Clin Cancer Res, 7, 1698 (2001)
  17. Méhes, Ambros, Gadner, Detecting disseminated solid tumor cells in hematopoietic samples: methodological aspects, 10.1163/15685590152492918
  18. Warzynski Michael J., Graham David M., Axtell Richard A., Higgins James V., Hammers Yuki A., Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients, 10.1002/cyto.10159
  19. Trager C., Quantitative Analysis of Tyrosine Hydroxylase mRNA for Sensitive Detection of Neuroblastoma Cells in Blood and Bone Marrow, 10.1373/49.1.104
  20. Wu, Cancer Res, 46, 440 (1986)
  21. Mujoo, Cancer Res, 47, 1098 (1987)
  22. Ruan, Cancer Res, 52, 5725 (1992)
  23. Lammie, Int J Oncol, 3, 909 (1993)
  24. Komada, Br J Haematol, 54, 711 (1986)
  25. Mechterheimer, Cancer, 71, 237 (1993)
  26. Oren, Mol Cell Biol, 10, 4007 (1990)
  27. Lipinski, Int J Cancer, 40, 81 (1987)
  28. Cheung N K, Von Hoff D D, Strandjord S E, Coccia P F, Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies., 10.1200/jco.1986.4.3.363
  29. Chang, Arch Pathol Lab Med, 113, 1343 (1989)
  30. Campana Dario, Coustan-Smith Elaine, Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia, 10.1053/beha.2002.0182
  31. Beiske, Am J Pathol, 141, 531 (1992)
  32. Cordell, J Histochem Cytochem, 32, 219 (1984)
  33. Faulkner Lawrence B., Garaventa Alberto, Paoli Antonella, Tintori Veronica, Tamburini Angela, Lacitignola Laura, Veltroni Marinella, Piccolo Maria Serena Lo, Viscardi Elisabetta, Milanaccio Claudia, Tondo Annalisa, Spinelli Serena, Bernini Gabriella, De Bernardi Bruno, In Vivo Cytoreduction Studies and Cell Sorting–Enhanced Tumor-Cell Detection in High-Risk Neuroblastoma Patients: Implications for Leukapheresis Strategies, 10.1200/jco.2000.18.22.3829
  34. Mehes, Clin Cancer Res, 7, 1969 (2001)
  35. Cheung, Med Pediatr Oncol, 36, 227 (2001)
  36. Moss, N Engl J Med, 324, 219 (1991)
  37. Rogers, J Clin Pathol, 42, 442 (1989)